Lumeva · MIG · Spain · Headache specialist · captured by Luis Ortega on 19 Apr 2026 · reviewed by Dr. Priya Raman on 22 Apr 2026
Verbatim as captured; never edited
Headache specialist at Hospital Clínic Barcelona raised drug interactions during a scientific exchange. They indicated this influences their current prescribing approach.
Human-approved by Dr. Priya Raman on 22 Apr 2026
Drug interactions: practice variation observed reported by headache specialist (ES).
helixor-private-llm-2026.05 · generated 19 Apr 2026, 10:00 UTC
AI summary
Drug interactions raised by headache specialist; suggest routing to HEOR.
Source spans used by the model
Headache specialist at Hospital Clínic Barcelona raised drug interactions during a scientific exchange. They indicated this influences their current prescribing approach.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Evidence gap | Evidence gap |
| Function | HEOR | HEOR |
| Priority | Medium | Medium |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 1 | 20% | 4.0 |
| Strategic alignment | 4 | 20% | 16.0 |
| Scientific importance | 2 | 15% | 6.0 |
| Urgency | 3 | 15% | 9.0 |
| Novelty | 5 | 10% | 10.0 |
| Actionability | 1 | 10% | 2.0 |
| Confidence | 2 | 5% | 2.0 |
| Breadth of occurrence | 4 | 5% | 4.0 |
| Total | Medium 53 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
18 Apr 2026 · Dr. Chloé Ivanova, Hospital Clínic Barcelona · MSL Luis Ortega
Insight
Reviewed 22 Apr 2026 by Dr. Priya Raman
Action
Initiative
Decision
Outcome
Closure